Spyre Therapeutics Inc (NAS:SYRE)
$ 22.46 -1.56 (-6.49%) Market Cap: 1.34 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 6.73 GF Score: 45/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1